GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,860,000 | -13.6% | 42,001 | -59.4% | 0.02% | -9.1% |
| Q2 2022 | $3,309,000 | +0.2% | 103,564 | +8.6% | 0.02% | +22.2% |
| Q1 2022 | $3,304,000 | +25.0% | 95,374 | +5.6% | 0.02% | +28.6% |
| Q4 2021 | $2,643,000 | +2596.9% | 90,288 | +3136.1% | 0.01% | +1300.0% |
| Q2 2021 | $98,000 | -19.7% | 2,790 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $122,000 | +662.5% | 2,991 | +724.0% | 0.00% | – |
| Q4 2020 | $16,000 | -23.8% | 363 | -6.2% | 0.00% | – |
| Q3 2020 | $21,000 | 0.0% | 387 | +14.8% | 0.00% | – |
| Q2 2020 | $21,000 | +5.0% | 337 | -52.8% | 0.00% | – |
| Q2 2017 | $20,000 | -89.5% | 714 | -87.9% | 0.00% | -100.0% |
| Q4 2015 | $191,000 | – | 5,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |